| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy has written risk assessments for the services it provides and the medicines it supplies on behalf of a prescribing service it is associated with. There are some processes in place to address some of the associated risks. However, it is not comprehensive enough to demonstrate the due diligence undertaken is sufficient to show that the controls adequately mitigate against the risks that had been identified. For example, some of the controls referred to prescribing algorithms and procedures, but the pharmacy had not seen these documents. The pharmacy has not gained further assurances about the validation methods used for the remote prescribing of weight loss treatments. And some risks continue to be overlooked, such as having a robust service level agreement in place to determine responsibilities and expectations. |
- Updated risk assessment highlighting new risks and controls including identity |
12/01/2026 | 12/01/2026 |
| 1.4 | The pharmacy does not have sufficient processes in place to ensure complaints and feedback are directed to the most appropriate department, between the associated prescribing service and pharmacy. This includes having a clear and up to date service level agreement setting out which service is responsible for the complaint or query. |
- Updated SLA outlining who is responsible for handling specific complaints and feedback from patients. |
12/01/2026 | 12/01/2026 |
Pharmacy inspections
Inspection reports and learning from inspections